Clinical Trial Update: Denosumab for Breast Cancer With Bone Mets [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for denosumab in breast cancer with bone metastases; trial has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-11-22